Helen Leavis1, Jochen Zwerina2, Bernhard Manger3, Ruth D E Fritsch-Stork4,5. 1. Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands. 2. Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich Collingasse 30, A-1140, Wien, Austria. 3. Department of Internal Medicine 3, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlange-Nürnberg, Erlangen, Germany. 4. Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich Collingasse 30, A-1140, Wien, Austria. ruth.fritsch-stork@wgkk.at. 5. Sigmund Freud University, Vienna, Austria. ruth.fritsch-stork@wgkk.at.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to provide an overview of the most relevant new disorders, disease entities, or disease phenotypes of primary immune deficiency disorders (PID) for the interested rheumatologist, using the new phenotypic classification by the IUIS (International Union of Immunological Societies) as practical guide. RECENT FINDINGS: Newly recognized disorders of immune dysregulation with underlying mutations in genes pertaining to the function of regulatory T cells (e.g., CTLA-4, LRBA, or BACH2) are characterized by multiple autoimmune diseases-mostly autoimmune cytopenia-combined with an increased susceptibility to infections due to hypogammaglobulinemia. On the other hand, new mutations (e.g., in NF-kB1, PI3Kδ, PI3KR1, PKCδ) leading to the clinical picture of CVID (common variable immmune deficiency) have been shown to increasingly associate with autoimmune diseases. The mutual association of autoimmune diseases with PID warrants increased awareness of immunodeficiencies when diagnosing autoimmune diseases with a possible need to initiate appropriate genetic tests.
PURPOSE OF REVIEW: The purpose of this review is to provide an overview of the most relevant new disorders, disease entities, or disease phenotypes of primary immune deficiency disorders (PID) for the interested rheumatologist, using the new phenotypic classification by the IUIS (International Union of Immunological Societies) as practical guide. RECENT FINDINGS: Newly recognized disorders of immune dysregulation with underlying mutations in genes pertaining to the function of regulatory T cells (e.g., CTLA-4, LRBA, or BACH2) are characterized by multiple autoimmune diseases-mostly autoimmune cytopenia-combined with an increased susceptibility to infections due to hypogammaglobulinemia. On the other hand, new mutations (e.g., in NF-kB1, PI3Kδ, PI3KR1, PKCδ) leading to the clinical picture of CVID (common variable immmune deficiency) have been shown to increasingly associate with autoimmune diseases. The mutual association of autoimmune diseases with PID warrants increased awareness of immunodeficiencies when diagnosing autoimmune diseases with a possible need to initiate appropriate genetic tests.
Authors: Steven M Holland; Frank R DeLeo; Houda Z Elloumi; Amy P Hsu; Gulbu Uzel; Nina Brodsky; Alexandra F Freeman; Andrew Demidowich; Joie Davis; Maria L Turner; Victoria L Anderson; Dirk N Darnell; Pamela A Welch; Douglas B Kuhns; David M Frucht; Harry L Malech; John I Gallin; Scott D Kobayashi; Adeline R Whitney; Jovanka M Voyich; James M Musser; Cristina Woellner; Alejandro A Schäffer; Jennifer M Puck; Bodo Grimbacher Journal: N Engl J Med Date: 2007-09-19 Impact factor: 91.245
Authors: Emanuela Castigli; Stephen A Wilson; Lilit Garibyan; Rima Rachid; Francisco Bonilla; Lynda Schneider; Raif S Geha Journal: Nat Genet Date: 2005-07-10 Impact factor: 38.330
Authors: C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs Journal: Nat Genet Date: 2001-01 Impact factor: 38.330
Authors: Klaus Warnatz; Ulrich Salzer; Marta Rizzi; Beate Fischer; Sylvia Gutenberger; Joachim Böhm; Anne-Kathrin Kienzler; Qiang Pan-Hammarström; Lennart Hammarström; Mirzokhid Rakhmanov; Michael Schlesier; Bodo Grimbacher; Hans-Hartmut Peter; Hermann Eibel Journal: Proc Natl Acad Sci U S A Date: 2009-08-06 Impact factor: 11.205
Authors: Mark S Anderson; Emily S Venanzi; Ludger Klein; Zhibin Chen; Stuart P Berzins; Shannon J Turley; Harald von Boehmer; Roderick Bronson; Andrée Dierich; Christophe Benoist; Diane Mathis Journal: Science Date: 2002-10-10 Impact factor: 47.728
Authors: Menno C van Zelm; Ismail Reisli; Mirjam van der Burg; Diana Castaño; Carel J M van Noesel; Maarten J D van Tol; Cristina Woellner; Bodo Grimbacher; Pablo J Patiño; Jacques J M van Dongen; José L Franco Journal: N Engl J Med Date: 2006-05-04 Impact factor: 91.245
Authors: Bodo Grimbacher; Andreas Hutloff; Michael Schlesier; Erik Glocker; Klaus Warnatz; Ruth Dräger; Hermann Eibel; Beate Fischer; Alejandro A Schäffer; Hans W Mages; Richard A Kroczek; Hans H Peter Journal: Nat Immunol Date: 2003-02-10 Impact factor: 25.606
Authors: Claudia Wehr; Teemu Kivioja; Christian Schmitt; Berne Ferry; Torsten Witte; Efrem Eren; Marcela Vlkova; Manuel Hernandez; Drahomira Detkova; Philip R Bos; Gonke Poerksen; Horst von Bernuth; Ulrich Baumann; Sigune Goldacker; Sylvia Gutenberger; Michael Schlesier; Florence Bergeron-van der Cruyssen; Magali Le Garff; Patrice Debré; Roland Jacobs; John Jones; Elizabeth Bateman; Jiri Litzman; P Martin van Hagen; Alessandro Plebani; Reinhold E Schmidt; Vojtech Thon; Isabella Quinti; Teresa Espanol; A David Webster; Helen Chapel; Mauno Vihinen; Eric Oksenhendler; Hans Hartmut Peter; Klaus Warnatz Journal: Blood Date: 2007-09-26 Impact factor: 22.113
Authors: M Jamee; S Hosseinzadeh; N Sharifinejad; M Zaki-Dizaji; M Matloubi; M Hasani; S Baris; M Alsabbagh; B Lo; G Azizi Journal: Clin Exp Immunol Date: 2021-05-03 Impact factor: 5.732
Authors: Lucia Leonardi; Beatrice Rivalta; Caterina Cancrini; Elena Chiappini; Claudio Cravidi; Carlo Caffarelli; Sara Manti; Mauro Calvani; Alberto Martelli; Michele Miraglia Del Giudice; Marzia Duse; Gian Luigi Marseglia; Fabio Cardinale Journal: Acta Biomed Date: 2020-09-15